212 related articles for article (PubMed ID: 10766187)
1. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin.
Bastian BC; Kashani-Sabet M; Hamm H; Godfrey T; Moore DH; Bröcker EB; LeBoit PE; Pinkel D
Cancer Res; 2000 Apr; 60(7):1968-73. PubMed ID: 10766187
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 is a candidate oncogene in cutaneous melanoma.
Sauter ER; Yeo UC; von Stemm A; Zhu W; Litwin S; Tichansky DS; Pistritto G; Nesbit M; Pinkel D; Herlyn M; Bastian BC
Cancer Res; 2002 Jun; 62(11):3200-6. PubMed ID: 12036934
[TBL] [Abstract][Full Text] [Related]
3. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ.
Yamaura M; Takata M; Miyazaki A; Saida T
Arch Dermatol; 2005 Nov; 141(11):1413-8. PubMed ID: 16301388
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes.
Gerami P; Mafee M; Lurtsbarapa T; Guitart J; Haghighat Z; Newman M
Arch Dermatol; 2010 Mar; 146(3):273-8. PubMed ID: 20231497
[TBL] [Abstract][Full Text] [Related]
5. Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8.
van Gils W; Kilic E; Brüggenwirth HT; Vaarwater J; Verbiest MM; Beverloo B; van Til-Berg ME; Paridaens D; Luyten GP; de Klein A
Melanoma Res; 2008 Feb; 18(1):10-5. PubMed ID: 18227702
[TBL] [Abstract][Full Text] [Related]
6. Differences in chromosomal aberrations between nodular and superficial spreading malignant melanoma detected by interphase cytogenetics.
Poetsch M; Woenckhaus C; Dittberner T; Pambor M; Lorenz G; Herrmann FH
Lab Invest; 1998 Jul; 78(7):883-8. PubMed ID: 9690566
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization.
Bastian BC; LeBoit PE; Hamm H; Bröcker EB; Pinkel D
Cancer Res; 1998 May; 58(10):2170-5. PubMed ID: 9605762
[TBL] [Abstract][Full Text] [Related]
8. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.
Jönsson G; Dahl C; Staaf J; Sandberg T; Bendahl PO; Ringnér M; Guldberg P; Borg A
Oncogene; 2007 Jul; 26(32):4738-48. PubMed ID: 17260012
[TBL] [Abstract][Full Text] [Related]
9. Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma.
Utikal J; Udart M; Leiter U; Peter RU; Krähn G
Int J Oncol; 2005 Mar; 26(3):597-605. PubMed ID: 15703813
[TBL] [Abstract][Full Text] [Related]
10. Rapid isolation and characterization of amplified DNA by chromosome microdissection: identification of IGF1R amplification in malignant melanoma.
Zhang J; Trent JM; Meltzer PS
Oncogene; 1993 Oct; 8(10):2827-31. PubMed ID: 8378091
[TBL] [Abstract][Full Text] [Related]
11. Extra copies of c-myc are more pronounced in nodular melanomas than in superficial spreading melanomas as revealed by fluorescence in situ hybridisation.
Treszl A; Adány R; Rákosy Z; Kardos L; Bégány A; Gilde K; Balázs M
Cytometry B Clin Cytom; 2004 Jul; 60(1):37-46. PubMed ID: 15221868
[TBL] [Abstract][Full Text] [Related]
12. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes.
Holzmann K; Kohlhammer H; Schwaenen C; Wessendorf S; Kestler HA; Schwoerer A; Rau B; Radlwimmer B; Döhner H; Lichter P; Gress T; Bentz M
Cancer Res; 2004 Jul; 64(13):4428-33. PubMed ID: 15231651
[TBL] [Abstract][Full Text] [Related]
13. High-level DNA amplifications are common genetic aberrations in B-cell neoplasms.
Werner CA; Döhner H; Joos S; Trümper LH; Baudis M; Barth TF; Ott G; Möller P; Lichter P; Bentz M
Am J Pathol; 1997 Aug; 151(2):335-42. PubMed ID: 9250147
[TBL] [Abstract][Full Text] [Related]
14. Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome.
Namiki T; Yanagawa S; Izumo T; Ishikawa M; Tachibana M; Kawakami Y; Yokozeki H; Nishioka K; Kaneko Y
Cancer Genet Cytogenet; 2005 Feb; 157(1):1-11. PubMed ID: 15676140
[TBL] [Abstract][Full Text] [Related]
15. Two cases of unusual acral melanocytic tumors: illustration of molecular cytogenetics as a diagnostic tool.
Takata M; Maruo K; Kageshita T; Ikeda S; Ono T; Shirasaki F; Takehara K; Bastian BC
Hum Pathol; 2003 Jan; 34(1):89-92. PubMed ID: 12605371
[TBL] [Abstract][Full Text] [Related]
16. The p44S10 locus, encoding a subunit of the proteasome regulatory particle, is amplified during progression of cutaneous malignant melanoma.
Ren S; Smith MJ; Louro ID; McKie-Bell P; Bani MR; Wagner M; Zochodne B; Redden DT; Grizzle WE; Wang Nd; Smith DI; Herbst RA; Bardenheuer W; Opalka B; Schütte J; Trent JM; Ben-David Y; Ruppert JM
Oncogene; 2000 Mar; 19(11):1419-27. PubMed ID: 10723133
[TBL] [Abstract][Full Text] [Related]
17. High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy.
Young TA; Burgess BL; Rao NP; Gorin MB; Straatsma BR
Mol Vis; 2007 Dec; 13():2328-33. PubMed ID: 18199974
[TBL] [Abstract][Full Text] [Related]
18. Gene-specific fluorescence in-situ hybridization analysis on tissue microarray to refine the region of chromosome 20q amplification in melanoma.
Koynova DK; Jordanova ES; Milev AD; Dijkman R; Kirov KS; Toncheva DI; Gruis NA
Melanoma Res; 2007 Feb; 17(1):37-41. PubMed ID: 17235240
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic application of cyclin D1 fluorescent in situ hybridization for histologically undetermined early lesions of acral melanoma in situ: A case series.
Cho-Vega JH; Cao T; Ledon J; Moller M; Avisar E; Elgart G; Tan JH; Fan YS; Grichnik JM
Ann Diagn Pathol; 2021 Feb; 50():151681. PubMed ID: 33341705
[TBL] [Abstract][Full Text] [Related]
20. Amplification and overexpression of HER-2/neu are uncommon in advanced stage melanoma.
Persons DL; Arber DA; Sosman JA; Borelli KA; Slovak ML
Anticancer Res; 2000; 20(3B):1965-8. PubMed ID: 10928135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
